Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy

被引:0
作者
Chimenti, M. S. [1 ]
Conigliaro, P. [1 ]
Navarini, L. [2 ]
Martina, F. M. [3 ,4 ]
Peluso, G. [5 ]
Birra, D. [5 ]
Sessa, P. [6 ]
Anzidei, M. [7 ]
Scolieri, P. [8 ]
Bruzzese, V. [8 ]
Santoboni, G. [9 ]
Cardello, P. [10 ]
Gremese, E. [5 ]
Afeltra, A. [2 ]
Valesini, G. [6 ]
Sebastiani, G. D. [11 ]
Perricone, R. [1 ]
Scrivo, R. [6 ]
机构
[1] Univ Roma Tor Vergata, Rheumatol Allergol & Clin Immunol, Rome, Italy
[2] Univ Campus Bio Med Roma, Dept Med, Unit Allergol Immunol & Rheumatol, Rome, Italy
[3] Univ Campus Bio Med Roma, Unita Diagnost Immagini, Rome, Italy
[4] Univ Campus Bio Med Roma, Dip Med, Rome, Italy
[5] Univ Cattolica Sacro Cuore, Ist Reumatol & Sci Affini, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[6] Sapienza Univ Roma, Reumatol, Dip Med Interna & Specialita Med, Rome, Italy
[7] Univ Sapienza Roma, Radiol, Dip Sci Radiol Oncol & Anatomopatol, Rome, Italy
[8] Osped Nuovo Regina Margherita, UOC Med Interna & Reumatol, Rome, Italy
[9] UOC Med Gen Polo, Rome, Italy
[10] Osped Belcolle Viterbo, UOC Radiol Diagnost & Interventist, Viterbo, Italy
[11] Azienda Osped San Camillo Forlanini, UO Reumatol, Rome, Italy
关键词
axial spondyloarthritis; ankylosing spondylitis; non-radiographic axial spondyloarthritis; magnetic resonance imaging; SOCIETY CLASSIFICATION CRITERIA; ALPHA BLOCKERS; BACK-PAIN; PREVALENCE; DISEASE; MANAGEMENT; RECOMMENDATIONS; DEFINITION; CHALLENGES; DIAGNOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Axial spondyloarthritides (axSpA) are a group of disorders that share similar pathogenetic mechanisms and clinical picture. The aim of this retrospective multicentric study was to evaluate demographic and clinical differences between ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA) patients. Methods Patients from 7 rheumatological centres in the Lazio region of Italy were included from January 1st, 2010 to April 1st, 2018, if they had undergone pelvic and/or spine radiographs or magnetic resonance imaging (MRI). Images were evaluated by one experienced radiologist in each centre who already had the clinical suspicion of axSpA. Clinical and therapeutic data were collected at the last observation visit. Categorical variables were presented with percentages and analysed by Chi squared test. Continuous variables were expressed as mean +/- standard deviation and compared using the parametric unpaired t-test or the non-parametric Mann-Whitney U-test, when appropriate. p-values <0.05 were considered significant. Results 210 axSpA patients were included: 65.2% with AS and 34.7% with nr-axSpA. When comparing the two groups, AS patients had longer disease duration, were older, were more frequently males, had a greater diagnostic delay and a higher body mass index than the nr-axSpA patients (p<0.0001, p<0.0001, p=0.003 p=0.007, and p=0.04, respectively). The peripheral joints of the nr-axSpA patients were more frequently involved, had higher frequency of inflammatory bowel disease, higher C-reactive protein levels and lower frequency of HLA-B27 positivity (p=0.005, p=0.007, p=0.01, and p=0.01, respectively). TNF inhibitors were used in 87.8% patients with AS and 78.3% with nr-axSpA (p=0.04). More fat metaplasia was observed on MRI in the nr-axSpA group than in the AS group at sacroiliac joints (p=0.003), and more backfills were detected in the AS group on spine-MRI (p=0.003). Spine-bone marrow oedema was more prevalent in AS than in nr-axSpA (p=0.04), and more sclerosis and backfill were found in AS (p=0.003 and p=0.01, respectively). Conclusion In clinical practice, distinctive features in AS and nr-axSpA patients emerged. Imaging is crucial in guiding the choice of treatment in order to control disease activity and inflammation.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 33 条
  • [1] Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?
    Baeten, Dominique
    Breban, Maxime
    Lories, Rik
    Schett, Georg
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 12 - 20
  • [2] Bohn R, 2018, CLIN EXP RHEUMATOL, V36, P263
  • [3] Braun J, 2018, CLIN EXP RHEUMATOL, V36, pS35
  • [4] CALIN A, 1994, J RHEUMATOL, V21, P2281
  • [5] Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients
    Conigliaro, Paola
    Chimenti, Maria Sole
    Ascolani, Marta
    Triggianese, Paola
    Novelli, Lucia
    Onali, Sara
    Lolli, Elisabetta
    Calabrese, Emma
    Petruzziello, Carmelina
    Pallone, Francesco
    Perricone, Roberto
    Biancone, Livia
    [J]. AUTOIMMUNITY REVIEWS, 2016, 15 (02) : 184 - 190
  • [6] D'Angelo S, 2008, CLIN EXP RHEUMATOL, V26, P1005
  • [7] DOUGADOS M, 1988, J RHEUMATOL, V15, P302
  • [8] Increased Body Mass Index in Ankylosing Spondylitis Is Associated with Greater Burden of Symptoms and Poor Perceptions of the Benefits of Exercise
    Durcan, Laura
    Wilson, Fiona
    Conway, Richard
    Cunnane, Gaye
    O'Shea, Finbar D.
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (12) : 2310 - 2314
  • [9] The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts
    Favalli, Ennio Giulio
    Becciolini, Andrea
    Caporali, Roberto
    Todoerti, Monica
    Iannone, Florenzo
    Dinoia, Liliana
    Sebastiani, Marco
    Spinella, Amelia
    Gremese, Elisa
    Cianci, Francesco
    Atzeni, Fabiola
    Bandinelli, Francesca
    Ferraccioli, Gianfranco
    Lapadula, Giovanni
    [J]. AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1251 - 1258
  • [10] Definition of disease duration in ankylosing spondylitis
    Feldtkeller, Ernst
    Erlendsson, Jon
    [J]. RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) : 693 - 696